We performed proteomics analysis, pathway-based Superarray assay, as well as quantitative RT-PCR to gain molecular insight into the mechanism(s) of GHR-deficiency-mediated NAFLD. This evidence concerns the gene GHR and metabolic dysfunction-associated steatotic liver disease.